Thermo Fisher Scientific Stock News

ZURICH--(BUSINESS WIRE)-- #LCMS--Biognosys, a leading developer and provider of next-generation proteomics technology and solutions, and Thermo Fisher Scientific, the world leader in serving science with innovative technologies, purchasing convenience and pharmaceutical services, announced today that they have extended a co-marketing agreement to provide life science researchers with comprehensive mass spectrometry solutions to gain deep proteomics insights at a large scale. The agreement leverages the

Palladium Partners LLC decreased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 49.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,222 shares of the medical research companys stock after selling 2,163 shares during the quarter. Palladium Partners []

New Jersey, United States,- Verified Market Research has recently published a research report titled, “Protein A Resin Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application”. Primary and secondary research methodologies have been used to

CMI Research has released the latest version of its survey report on the Liquid Chromatography Mass Spectrometry (LCMS) Market, which includes 100+ market data tables, a pie chart, graphs and figures scattered over pages. The market is currently expanding its

This unique IVD Products market research study also presents important data about COVID-19 and its effects on different industries. It further explains how industries are trying to come out of this pandemic condition to set their business in the market

Key Companies in Next-Generation Sequencing Market are Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., QIAGEN, BGI, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., PierianDx Key Companies in Next-Generation Sequencing Market are Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., QIAGEN, BGI, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., PierianDx

The Artificial Pancreas Device System (APDS) Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Artificial Pancreas Device System (APDS) Market report

The Diabetes Injection Pens Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Diabetes Injection Pens Market report is to supply an

The Biochips Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Biochips Market report is to supply an in-depth view and strategic

Northbrook, IL, USA, 2021-Dec-14 — /EPR Network/ — According to the new market research report Single use Bioreactors Market is projected to reach USD 3.9 [read full press release…]

The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the RSV Diagnostics industry. This wide-ranging market research report acts as a backbone for the success of business

The global Life Science and Chemical Instrumentation market size is projected to reach US$ 43080 million by 2026, from US$ 40760 million in 2020, at a CAGR of 5.3%% during 2021-2026. The major vendors covered: Agilent Technologies Inc, Bio-Rad Laboratories Inc, Becton, Dickinson, & Company, Bruker Corporation, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Danaher Corporation, Shimadzu Corporation, Waters Corporation The global Life Science and Chemical Instrumentation market size is projected to reach US$ 43080 million by 2026, from US$ 40760 million in 2020, at a CAGR of 5.3%% during 2021-2026. The major vendors covered: Agilent Technologies Inc, Bio-Rad Laboratories Inc, Becton, Dickinson, & Company, Bruker Corporation, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Danaher Corporation, Shimadzu Corporation, Waters Corporation

Thermo Fisher's (TMO) Oncomine Dx Target Test will allow clinicians to use FFPE tissue samples to spot patients in the United States who may benefit from the important new therapy.

New Jersey, United States,- Verified Market Research has recently published a research report titled, Laboratory Analytical Instruments Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used to

Legacy Bridge LLC boosted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,592 shares of the medical research companys stock after purchasing an additional 50 shares during the []